Dr. Michael E. Contreras, MD

Dr. Contreras practices at Core Dermatology in Denver, Colorado.

Dr. Contreras' NPI, 1457367013, was assigned on August 1, 2006. Dr. Contreras graduated from The University of New Mexico School of Medicine in 2001. Dr. Contreras holds Colorado license 48593.

Dr. Contreras' primary practice is Core Dermatology, at 425 S Cherry St, Denver, CO 80246 in Denver County. The practice phone is (303) 355-3000.

Dr. Contreras' primary practice is Core Dermatology in Denver, Colorado. The medical group on file is Core Dermatology. Dmand AI also links Dr. Contreras to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Contreras practices. Vendor and product names are available with a free account.

Dermatology is Dr. Contreras' primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Contreras is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Contreras' licenses on file in 2 states: Colorado and New Mexico.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, contact dermatitis, hives, itchy rashes, minor head injury and minor injury to a limb among the conditions Dr. Contreras treats.

CMS data shows 4,310 Medicare services from Dr. Contreras across 15 procedure codes in 2024, for 361 Medicare patients. Medicare paid $72,717 for them. Every service was in an office.

CMS counts 361 Medicare patients who saw Dr. Contreras in 2024. The largest group is 65 to 74, with 173 patients. 72% of them have high cholesterol, and 54% have high blood pressure. Their average risk score is 0.93, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Contreras' median patient age at 65, with 39% women.

In 2024, Dr. Contreras wrote 283 Medicare Part D claims for 132 patients. 98% of them were for generic drugs. CMS names the drug for 169 of them, across 7 drugs with 11 or more claims each, at $2,554 in total drug cost. In 2023, CMS named 164 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Contreras for performance year 2024, reported as part of a group. Dr. Contreras accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 455 procedures of removal of skin lesions by Dr. Contreras, more than 86% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Contreras. Dr. Contreras' most frequent co-authors are Joel Lee Cohen, MD and Joel Cohen, MD.

CMS Open Payments shows 515 general payments to Dr. Contreras from 37 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 72% of the total. Galderma Laboratories, L.P. paid the most, $48,684.

Dmand AI lists 1 award for Dr. Contreras.

Dr. Contreras graduated from The University of New Mexico School of Medicine in 2001. Dr. Contreras is a member of AAD.

Dr. Contreras is in network with 17 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.